JP2018538308A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018538308A5 JP2018538308A5 JP2018532038A JP2018532038A JP2018538308A5 JP 2018538308 A5 JP2018538308 A5 JP 2018538308A5 JP 2018532038 A JP2018532038 A JP 2018532038A JP 2018532038 A JP2018532038 A JP 2018532038A JP 2018538308 A5 JP2018538308 A5 JP 2018538308A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antibody
- use according
- bladder
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 37
- 239000007788 liquid Substances 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 206010005003 Bladder cancer Diseases 0.000 claims 4
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 4
- 238000009098 adjuvant therapy Methods 0.000 claims 4
- 239000007864 aqueous solution Substances 0.000 claims 4
- 201000005112 urinary bladder cancer Diseases 0.000 claims 4
- -1 hexyl 5-ALA ester Chemical class 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 238000009799 cystectomy Methods 0.000 claims 2
- 238000009099 neoadjuvant therapy Methods 0.000 claims 1
- 229960003301 nivolumab Drugs 0.000 claims 1
- 229960002621 pembrolizumab Drugs 0.000 claims 1
- 238000002271 resection Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1522311.8 | 2015-12-17 | ||
| GBGB1522311.8A GB201522311D0 (en) | 2015-12-17 | 2015-12-17 | Use |
| PCT/EP2016/081798 WO2017103280A1 (en) | 2015-12-17 | 2016-12-19 | Intravesical therapy for bladder cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018538308A JP2018538308A (ja) | 2018-12-27 |
| JP2018538308A5 true JP2018538308A5 (enExample) | 2020-02-06 |
Family
ID=55311161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018532038A Pending JP2018538308A (ja) | 2015-12-17 | 2016-12-19 | 膀胱癌のための膀胱内療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20180371101A1 (enExample) |
| EP (1) | EP3390448B1 (enExample) |
| JP (1) | JP2018538308A (enExample) |
| KR (1) | KR102878726B1 (enExample) |
| CN (1) | CN108699147B (enExample) |
| AU (1) | AU2016372570B2 (enExample) |
| BR (1) | BR112018012116A2 (enExample) |
| DK (1) | DK3390448T3 (enExample) |
| ES (1) | ES2981986T3 (enExample) |
| FI (1) | FI3390448T3 (enExample) |
| GB (1) | GB201522311D0 (enExample) |
| PL (1) | PL3390448T3 (enExample) |
| WO (1) | WO2017103280A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102434314B1 (ko) | 2015-09-01 | 2022-08-19 | 아게누스 인코포레이티드 | 항-pd-1 항체 및 이를 이용하는 방법 |
| GB201522311D0 (en) * | 2015-12-17 | 2016-02-03 | Photocure Asa | Use |
| WO2018106864A1 (en) | 2016-12-07 | 2018-06-14 | Agenus Inc. | Antibodies and methods of use thereof |
| JP6617220B2 (ja) * | 2017-12-01 | 2019-12-11 | Ｓｂｉファーマ株式会社 | 免疫チェックポイント阻害剤による抗腫瘍効果を増強するための医薬組成物 |
| WO2024184417A1 (en) | 2023-03-07 | 2024-09-12 | Photocure Asa | Therapy for bladder cancer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE202076T1 (de) | 1995-03-10 | 2001-06-15 | Photocure Asa | Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie |
| EP2243493A1 (en) | 2002-07-03 | 2010-10-27 | Ono Pharmaceutical Co., Ltd. | Immunopotentiative composition |
| GB0406917D0 (en) | 2004-03-26 | 2004-04-28 | Photocure Asa | Compounds |
| SI2170959T1 (sl) | 2007-06-18 | 2014-04-30 | Merck Sharp & Dohme B.V. | Protitelesa proti receptorjem pd-1 za humano programirano smrt |
| US8168757B2 (en) | 2008-03-12 | 2012-05-01 | Merck Sharp & Dohme Corp. | PD-1 binding proteins |
| BRPI0919377A2 (pt) * | 2008-09-26 | 2016-09-27 | Dana Farber Cancer Inst Inc | anticorpo isolado ou um fragmento ligante de antígeno do memso, ácido nucleico isolado, vetor, célula hospedeira, composição farmacêutica, método de produzir o referido anticorpo ou fragmento, uso dos mesmos, e composição compreendendo o referido anticorpo ou fragmento |
| FI4209510T3 (fi) | 2008-12-09 | 2024-03-22 | Hoffmann La Roche | Anti-PD-L1-vasta-aineita ja niiden käyttö T-solutoiminnan tehostamiseksi |
| TW202114735A (zh) | 2011-08-01 | 2021-04-16 | 美商建南德克公司 | 利用pd-1軸結合拮抗劑及mek抑制劑治療癌症之方法 |
| EP3763741A1 (en) | 2011-11-28 | 2021-01-13 | Merck Patent GmbH | Anti-pd-l1 antibodies and uses thereof |
| WO2013181452A1 (en) | 2012-05-31 | 2013-12-05 | Genentech, Inc. | Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists |
| EP3365062B1 (en) * | 2015-10-19 | 2024-09-18 | CG Oncology, Inc. | Methods of treating solid or lymphatic tumors by combination therapy |
| GB201522309D0 (en) * | 2015-12-17 | 2016-02-03 | Photocure Asa | Use |
| GB201522311D0 (en) * | 2015-12-17 | 2016-02-03 | Photocure Asa | Use |
-
2015
- 2015-12-17 GB GBGB1522311.8A patent/GB201522311D0/en not_active Ceased
-
2016
- 2016-12-19 DK DK16819062.7T patent/DK3390448T3/da active
- 2016-12-19 BR BR112018012116-9A patent/BR112018012116A2/en active IP Right Grant
- 2016-12-19 AU AU2016372570A patent/AU2016372570B2/en active Active
- 2016-12-19 EP EP16819062.7A patent/EP3390448B1/en active Active
- 2016-12-19 US US16/063,169 patent/US20180371101A1/en not_active Abandoned
- 2016-12-19 ES ES16819062T patent/ES2981986T3/es active Active
- 2016-12-19 PL PL16819062.7T patent/PL3390448T3/pl unknown
- 2016-12-19 FI FIEP16819062.7T patent/FI3390448T3/fi active
- 2016-12-19 WO PCT/EP2016/081798 patent/WO2017103280A1/en not_active Ceased
- 2016-12-19 KR KR1020187020008A patent/KR102878726B1/ko active Active
- 2016-12-19 JP JP2018532038A patent/JP2018538308A/ja active Pending
- 2016-12-19 CN CN201680079683.1A patent/CN108699147B/zh active Active
-
2019
- 2019-04-18 US US16/388,379 patent/US11066478B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018538308A5 (enExample) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| RU2012118974A (ru) | Комбинации ингибитора pi3k и ингибитора мек | |
| EA201792541A3 (ru) | Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени | |
| AR072442A1 (es) | Metodo para la terapia del cancer, uso, kit | |
| EA201390840A1 (ru) | Полициклический lpaантагонист и его применение | |
| CR20190247A (es) | Métodos para el tratamiento de la atrofia muscular y enfermedad ósea con el uso de proteínas trap híbridas novedosas del ligando actriib | |
| EA201391263A1 (ru) | Комбинированные терапии гематологических опухолей | |
| ATE522225T1 (de) | Verwendung des peptids phpfhlfvy (renin- inhibitor) in anti-angiogenischer therapie von gewissen erkrankungen | |
| FI3484446T3 (fi) | Vasta-ainekoostumuksia | |
| RU2018146886A (ru) | Пути терапевтического применения ингибитора c-raf | |
| IL311873A (en) | Combination therapy for treating malignancies | |
| EA201991704A3 (ru) | Моноклональные антитела против ингибитора пути тканевого фактора (tfpi) | |
| ATE553772T1 (de) | Verwendung von lvv-hämorphin-6 und optional af12198 als therapeutische(s) mittel | |
| EA201592287A1 (ru) | Замещенные тетрагидрокарбазольные и карбазолкарбоксамидные соединения | |
| FI3390448T3 (fi) | Intravesikaalinen hoito virtsarakon syöpää varten | |
| JP2020502198A5 (enExample) | ||
| FI3463436T3 (fi) | Rokote yhdistelmänä immuunivasteen tarkastuspisteen estäjän kanssa käytettäväksi hoidettaessa syöpää | |
| RU2014145841A (ru) | Терапевтический биопрепарат для лечения гепатоцеллюлярной карциномы | |
| JP2012522841A5 (enExample) | ||
| AU2020256847B2 (en) | Method of treating tumours | |
| JP2018537514A5 (enExample) | ||
| AR084216A1 (es) | Composiciones y metodos para tratar el cancer usando un inhibidor de pi3k e inhibidor de mek, kit | |
| KR102787188B1 (ko) | 방광암에 대한 신보조 요법 | |
| JP2019501161A5 (enExample) |